*A. Psyrri, M. Kwong, L. Lekakis, M. Kassar , C. Sasaki, L. Wilson, B. Haffty, Y.H. Son, D.A. Ross, P. Weinberger, G. Chung, D. Zelterman, B.A. Burtness and D.L. Cooper;
Phase II trial of PFL-induction chemotherapy followed by concomitant cisplatin chemoradiotherapy (CRT) for head and neck squamous cell cancer (HNSCC): long-term follow-up.
(Journal of Clinical Oncology, Vol 22, Number 15, 2004).
